{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:08:03Z","timestamp":1788815283974,"version":"build-2803163510"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["BIO-0139"],"award-info":[{"award-number":["BIO-0139"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000382","name":"Society for Endocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["JDC2024-054493-I"],"award-info":[{"award-number":["JDC2024-054493-I"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-136227OB-I00 MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2022-136227OB-I00 MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012514","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red-Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.beem.2026.102156","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:29:17Z","timestamp":1787034557000},"page":"102156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["HeteroGeNETics: Neuroendocrine tumor genetics reflect their heterogeneous complex diversity"],"prefix":"10.1016","author":[{"given":"Laura","family":"Guti\u00e9rrez-Camacho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Gonz\u00e1lez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ruiz-Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Qui\u00f1onero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Ib\u00e1\u00f1ez-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justo P.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Pedraza-Arevalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2026.102156_bib1","first-page":"471","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"68","author":"Cives","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.beem.2026.102156_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11154-018-9465-0","article-title":"Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors","volume":"19","author":"Pedraza-Ar\u00e9valo","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2026.102156_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.15798","article-title":"Epidemiology of neuroendocrine neoplasms in the US","volume":"8","author":"Dasari","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.beem.2026.102156_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.beem.2026.102156_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11154-022-09771-4","article-title":"The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities","volume":"24","author":"Bl\u00e1zquez-Encinas","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2026.102156_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s42003-020-01479-y","article-title":"Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression","volume":"3","author":"Di Domenico","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.beem.2026.102156_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-026-02697-4","article-title":"Multi-omic profiles of neuroendocrine neoplasms of the pancreas: an integrated landscape","author":"Bevere","year":"2026","journal-title":"Mol Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12022-020-09660-z","article-title":"Genomics of high-grade neuroendocrine neoplasms: well-differentiated neuroendocrine tumor with high-grade features (G3 NET) and neuroendocrine carcinomas (NEC) of various anatomic sites","volume":"32","author":"Uccella","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giaa112","article-title":"A molecular map of lung neuroendocrine neoplasms","volume":"9","author":"Gabriel","year":"2020","journal-title":"Gigascience"},{"key":"10.1016\/j.beem.2026.102156_bib10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/path.4853","article-title":"Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D","volume":"241","author":"Simbolo","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib11","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1038\/s41467-021-27341-1","article-title":"The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics","volume":"12","author":"Tang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib12","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1093\/oncolo\/oyab044","article-title":"Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901","volume":"27","author":"Peng","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.beem.2026.102156_bib13","unstructured":"Sexton-Oates A., Mathian \u00c9., Candeli N., et al. Deep molecular profiling of lung neuroendocrine 1 tumours and supra-carcinoids. 2026. Molecular Cancer. In press."},{"key":"10.1016\/j.beem.2026.102156_bib14","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1038\/ncomms4518","article-title":"Frequent mutations in chromatin-remodeling genes in pulmonary carcinoids","volume":"5","author":"Fernandez-Cuesta","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib15","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","article-title":"Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib16","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1038\/s41467-019-11276-9","article-title":"Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids","volume":"10","author":"Alcala","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9440(10)65289-3","article-title":"Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms","volume":"154","author":"G\u00f6rtz","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/hupa.2001.22762","article-title":"Loss of heterozygosity on chromosome arm 11q in lung carcinoids","volume":"32","author":"Petzmann","year":"2001","journal-title":"Human Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ajpath.2011.05.028","article-title":"Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome","volume":"179","author":"Swarts","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib20","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/jc.2014-1560","article-title":"Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients","volume":"99","author":"De Laat","year":"2014","journal-title":"J Clin Endocrinol & Metab"},{"key":"10.1016\/j.beem.2026.102156_bib21","doi-asserted-by":"crossref","first-page":"E374","DOI":"10.1210\/jc.2013-2782","article-title":"MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids","volume":"99","author":"Swarts","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102156_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/cncr.20825","article-title":"Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1","volume":"103","author":"Sachithanandan","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.cllc.2025.03.009","article-title":"Lung carcinoid tumors with potentially actionable genomic alterations and responses to targeted therapies","volume":"26","author":"Waliany","year":"2025","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib24","first-page":"4269","article-title":"Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung","volume":"30","author":"Pelosi","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib25","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.2147\/OTT.S117161","article-title":"Role of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysis","volume":"9","author":"Yang","year":"2016","journal-title":"Oncol Targets Ther"},{"key":"10.1016\/j.beem.2026.102156_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12957-018-1413-7","article-title":"MGMT promoter methylation and 1p\/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma","volume":"16","author":"Lei","year":"2018","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-025-09847-2","article-title":"Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the Lung","volume":"36","author":"Melhorn","year":"2025","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1440-1827.2012.02845.x","article-title":"Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors","volume":"62","author":"Lee","year":"2012","journal-title":"Pathol Int"},{"key":"10.1016\/j.beem.2026.102156_bib29","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/modpathol.2014.74","article-title":"Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study","volume":"27","author":"Mairinger","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000381454","article-title":"Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression","volume":"101","author":"Rapa","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2026.102156_bib31","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-19-0214","article-title":"Integrative genomic characterization identifies molecular subtypes of lung carcinoids","volume":"79","author":"Laddha","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/path.6352","article-title":"Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid","volume":"264","author":"Domingo-Sabugo","year":"2024","journal-title":"J Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib33","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/ijc.33995","article-title":"The single-cell transcriptional landscape of lung carcinoid tumors","volume":"150","author":"Bischoff","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jtho.2024.11.018","article-title":"Identification of defined molecular subgroups on the basis of immunohistochemical analyses and potential therapeutic vulnerabilities of pulmonary carcinoids","volume":"20","author":"Leunissen","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1186\/s12967-023-04754-8","article-title":"Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery","volume":"21","author":"Bl\u00e1zquez-Encinas","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.beem.2026.102156_bib36","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/cancers11101508","article-title":"Orthopedia homeobox (OTP) in pulmonary neuroendocrine tumors: the diagnostic value and possible molecular interactions","volume":"11","author":"Moonen","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2026.102156_bib37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/his.14873","article-title":"Ascl1 and OTP tumour expressions are associated with disease-free survival in lung atypical carcinoids","volume":"82","author":"Centonze","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.beem.2026.102156_bib38","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S1470-2045(24)00374-7","article-title":"Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies","volume":"26","author":"Sen","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib39","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/JTO.0000000000000589","article-title":"Pulmonary large-cell neuroendocrine carcinoma: from epidemiology to therapy","volume":"10","author":"Fasano","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib40","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.21037\/tlcr-20-269","article-title":"New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts","volume":"9","author":"Lantuejoul","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib41","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jtho.2018.02.002","article-title":"New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management","volume":"13","author":"Derks","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib42","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41467-018-03099-x","article-title":"Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors","volume":"9","author":"George","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1078-0432.CCR-17-1921","article-title":"Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome","volume":"24","author":"Derks","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib44","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1158\/1078-0432.CCR-19-0556","article-title":"The prognostic and therapeutic role of genomic subtyping by sequencing tumor or cell-free DNA in pulmonary large-cell neuroendocrine carcinoma","volume":"26","author":"Zhuo","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107454","article-title":"Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary large-cell neuroendocrine carcinoma","volume":"188","author":"Burns","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib46","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1158\/1078-0432.CCR-24-0361","article-title":"YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities","volume":"30","author":"Stewart","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib47","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1038\/s41467-025-63091-0","article-title":"Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma","volume":"16","author":"Nassar","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib48","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6074.IO2026-LB-A004","article-title":"Abstract LB-A004: DAREON-7: Phase I open-label dose-escalation\/-expansion study of first-line obrixtamig (BI 764532) plus chemotherapy in patients with DLL3-positive neuroendocrine carcinomas","volume":"14","author":"Chauhan","year":"2026","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.beem.2026.102156_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.lungcan.2019.02.022","article-title":"Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)","volume":"130","author":"Hermans","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.lungcan.2022.01.007","article-title":"The genomic mutational landscape and its correlation with TMB, PD-L1 expression and CD8+ T cell infiltration in Chinese lung large cell neuroendocrine carcinoma","volume":"166","author":"Li","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920937972","article-title":"PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 \u201cEPNEC\u201d study","volume":"12","author":"Arpin","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216816","article-title":"Patient-derived tumoroid models of pulmonary large-cell neuroendocrine carcinoma: a promising tool for personalized medicine and developing novel therapeutic strategies","volume":"588","author":"Yokota","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.beem.2026.102156_bib53","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.ccell.2023.11.007","article-title":"Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites","volume":"41","author":"Dayton","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2026.102156_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtho.2022.10.002","article-title":"SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection","volume":"18","author":"Wang","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.beem.2026.102156_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.beem.2026.102156_bib57","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41586-024-07177-7","article-title":"Evolutionary trajectories of small cell lung cancer under therapy","volume":"627","author":"George","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.beem.2026.102156_bib58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40164-024-00548-w","article-title":"Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities","volume":"13","author":"Zhang","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib59","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.semcancer.2022.03.015","article-title":"Evolution of small cell lung cancer tumor mutation: from molecular mechanisms to novel viewpoints","volume":"86","author":"Guan","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.beem.2026.102156_bib60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2023.12.004","article-title":"Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies","volume":"187","author":"Liu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.beem.2026.102156_bib61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12022-014-9320-0","article-title":"Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors","volume":"25","author":"Pelosi","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib62","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41571-024-00914-x","article-title":"Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer","volume":"21","author":"Sen","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib63","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2026.102156_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100308","article-title":"Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities","volume":"7","author":"Simbolo","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.beem.2026.102156_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1060","article-title":"In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer","volume":"12","author":"Szeitz","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.beem.2026.102156_bib66","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jtho.2022.11.008","article-title":"An interleukin-15 superagonist enables antitumor efficacy of natural killer cells against all molecular variants of SCLC","volume":"18","author":"Fousek","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib67","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/s41467-022-29517-9","article-title":"Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models","volume":"13","author":"Lissa","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib68","article-title":"Genomic and transcriptomic characterization of relapsed SCLC through rapid research autopsy","volume":"2","author":"Chen","year":"2021","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.beem.2026.102156_bib69","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41392-025-02378-6","article-title":"Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.beem.2026.102156_bib70","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1038\/s41467-025-60141-5","article-title":"FOXA2 promotes metastatic competence in small cell lung cancer","volume":"16","author":"Kawasaki","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib71","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ccell.2024.06.012","article-title":"Mammalian SWI\/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer","volume":"42","author":"Duplaquet","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2026.102156_bib72","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1158\/1541-7786.MCR-20-1006","article-title":"Sox2 Is an oncogenic driver of small-cell lung cancer and promotes the classic neuroendocrine subtype","volume":"19","author":"Voigt","year":"2021","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib73","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41556-023-01210-z","article-title":"KDM6A epigenetically regulates subtype plasticity in small cell lung cancer","volume":"25","author":"Duplaquet","year":"2023","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.beem.2026.102156_bib74","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/s41388-025-03481-2","article-title":"Integrative epigenome and transcriptome analyses reveal transcriptional programs differentially regulated by ASCL1 and NEUROD1 in small cell lung cancer","volume":"44","author":"Takumida","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.beem.2026.102156_bib75","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114841","article-title":"Promoters of ASCL1- and NEUROD1-dependent genes are specific targets of lurbinectedin in SCLC cells","volume":"14","author":"Costanzo","year":"2022","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.beem.2026.102156_bib76","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s10020-025-01267-6","article-title":"ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer","volume":"31","author":"Guti\u00e9rrez","year":"2025","journal-title":"Mol Med"},{"key":"10.1016\/j.beem.2026.102156_bib77","doi-asserted-by":"crossref","first-page":"0908","DOI":"10.34133\/research.0908","article-title":"ARID1A governs genomic stability and proliferation in SCLC via c-MYC\/PARP1 suppression driving vulnerability to BET inhibitors","volume":"8","author":"Cao","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.beem.2026.102156_bib78","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1101\/gad.340133.120","article-title":"MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity","volume":"34","author":"Grunblatt","year":"2020","journal-title":"Genes Dev"},{"key":"10.1016\/j.beem.2026.102156_bib79","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1002\/cncr.33048","article-title":"Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy","volume":"126","author":"Park","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib80","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1158\/1078-0432.CCR-24-0466","article-title":"Detecting small cell transformation in patients with advanced EGFR mutant lung adenocarcinoma through epigenomic cfDNA profiling","volume":"30","author":"El Zarif","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib81","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/2159-8290.CD-20-1863","article-title":"Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation","volume":"11","author":"Quintanal-Villalonga","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beem.2026.102156_bib82","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/j.celrep.2020.02.052","article-title":"FGFR1 oncogenic activation reveals an alternative cell of origin of SCLC in Rb1\/p53 mice","volume":"30","author":"Ferone","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2026.102156_bib83","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1158\/0008-5472.CAN-20-4048","article-title":"Upregulation of FGF9 in lung adenocarcinoma transdifferentiation to small cell lung cancer","volume":"81","author":"Ishioka","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib84","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2022.01.008","article-title":"Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers","volume":"167","author":"Mc Leer","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib85","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ccell.2025.03.027","article-title":"Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation","volume":"43","author":"Teng","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2026.102156_bib86","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.197008","article-title":"EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy","volume":"11","author":"Ogino","year":"2026","journal-title":"JCI Insight"},{"key":"10.1016\/j.beem.2026.102156_bib87","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41392-022-01150-4","article-title":"Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer","volume":"7","author":"Tian","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.beem.2026.102156_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112803","article-title":"Comprehensive analysis of single-cell transcriptomics and genetic factors reveals the mechanisms and preventive strategies for the progression from pulmonary fibrosis to lung cancer","volume":"140","author":"Gu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.beem.2026.102156_bib89","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41421-024-00703-x","article-title":"Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer","volume":"10","author":"Jin","year":"2024","journal-title":"Cell Discov"},{"key":"10.1016\/j.beem.2026.102156_bib90","article-title":"Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities","volume":"5","author":"Desai","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.beem.2026.102156_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108048","article-title":"Spatial proteomic profiling reveals conserved prognostic immune microenvironment features across molecular subtypes in small cell lung cancer","volume":"222","author":"Zhai","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.beem.2026.102156_bib92","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jare.2025.06.017","article-title":"Integrative multi-omics profiling deciphers tumor microenvironment heterogeneity and immunotherapy vulnerabilities in lung neuroendocrine carcinomas","volume":"81","author":"Zhang","year":"2026","journal-title":"J Adv Res"},{"key":"10.1016\/j.beem.2026.102156_bib93","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing But NET: a review of neuroendocrine tumors and carcinomas","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.beem.2026.102156_bib94","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3892\/etm.2021.10613","article-title":"The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5","volume":"22","author":"Popa","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.beem.2026.102156_bib95","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/2159-8290.CD-21-0669","article-title":"Comprehensive genomic profiling of neuroendocrine carcinomas of the gastrointestinal system","volume":"12","author":"Yachida","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beem.2026.102156_bib96","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12022-021-09662-5","article-title":"Molecular pathology of well-differentiated gastro-entero-pancreatic neuroendocrine tumors","volume":"32","author":"Asa","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib97","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib98","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib99","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI67963","article-title":"The genomic landscape of small intestine neuroendocrine tumors","volume":"123","author":"Banck","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beem.2026.102156_bib100","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Francis","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2026.102156_bib101","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1038\/s41467-021-24812-3","article-title":"The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets","volume":"12","author":"van Riet","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib102","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1038\/s41467-021-26581-5","article-title":"Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine","volume":"12","author":"Elias","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib103","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00428-018-2450-x","article-title":"Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine","volume":"473","author":"Simbolo","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.beem.2026.102156_bib104","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1245\/s10434-014-4351-9","article-title":"Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors","volume":"22","author":"Crona","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib105","doi-asserted-by":"crossref","first-page":"17969","DOI":"10.1038\/s41598-025-01912-4","article-title":"Small intestinal neuroendocrine tumors lack early genomic drivers, acquire DNA repair defects and harbor hallmarks of low REST expression","volume":"15","author":"Bolduan","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2026.102156_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116500","article-title":"Single-cell RNA-seq of small-intestinal neuroendocrine tumors reveals the cell of origin and gene expression of early tumor development","volume":"44","author":"Sei","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2026.102156_bib107","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.70004","article-title":"Molecular alterations in high-grade neuroendocrine tumors of the small intestine","volume":"268","author":"Hercent","year":"2026","journal-title":"J Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib108","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/his.14252","article-title":"Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours","volume":"78","author":"Samsom","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.beem.2026.102156_bib109","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: The latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib110","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/cells14030188","article-title":"p27Kip1 and Tumors: Characterization of CDKN1B Variants Identified in MEN4 and Breast Cancer","volume":"14","author":"Bencivenga","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.beem.2026.102156_bib111","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.humpath.2013.06.019","article-title":"Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms","volume":"44","author":"Bottarelli","year":"2013","journal-title":"Human Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib112","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13073-022-01083-1","article-title":"Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors","volume":"14","author":"M\u00e4kinen","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.beem.2026.102156_bib113","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1186\/1471-2407-13-505","article-title":"Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization","volume":"13","author":"Hashemi","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib114","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gcc.20834","article-title":"Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors","volume":"50","author":"Cunningham","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/gcc.20561","article-title":"High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss","volume":"47","author":"Kulke","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib116","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1038\/s41598-018-22115-0","article-title":"Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors","volume":"8","author":"Walter","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2026.102156_bib117","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64136-3","article-title":"Comparative Genomic Hybridization Identifies Loss of 18q22-qter as an Early and Specific Event in Tumorigenesis of Midgut Carcinoids","volume":"158","author":"Kyt\u00f6l\u00e4","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib118","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ijc.1276","article-title":"Chromosome 18 deletions are common events in classical midgut carcinoid tumors","volume":"92","author":"L\u00f6llgen","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib119","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41467-025-57305-8","article-title":"Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors","volume":"16","author":"Patte","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/ERC-13-0419","article-title":"TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors","volume":"21","author":"Edfeldt","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12885-021-07786-9","article-title":"SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors","volume":"21","author":"Hofving","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib122","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41389-020-0221-4","article-title":"Loss of copy of MIR1-2 increases CDK4 expression in ileal neuroendocrine tumors","volume":"9","author":"Contractor","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.beem.2026.102156_bib123","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1159\/000530106","article-title":"Chromosome 18 Loss of Heterozygosity in Small Intestinal Neuroendocrine Tumours: Multi-Omic and Tumour Composition Analyses","volume":"113","author":"Waterfield","year":"2023","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2026.102156_bib124","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-15-0373","article-title":"Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor","volume":"22","author":"Karpathakis","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib125","doi-asserted-by":"crossref","first-page":"12303","DOI":"10.1038\/s41598-021-91934-5","article-title":"Differential methylation of G-protein coupled receptor signaling genes in gastrointestinal neuroendocrine tumors","volume":"11","author":"Byun","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2026.102156_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1184436","article-title":"Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors","volume":"14","author":"Klomp","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.beem.2026.102156_bib127","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/gcc.22850","article-title":"Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors","volume":"59","author":"Zhang","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib128","doi-asserted-by":"crossref","first-page":"417","DOI":"10.12688\/f1000research.130251.2","article-title":"Multiomic sequencing of paired primary and metastatic small bowel carcinoids","volume":"12","author":"Postel","year":"2023","journal-title":"F1000Res"},{"key":"10.1016\/j.beem.2026.102156_bib129","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4161\/epi.28936","article-title":"Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors","volume":"9","author":"Fotouhi","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.beem.2026.102156_bib130","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/modpathol.3800825","article-title":"Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)","volume":"20","author":"Choi","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib131","doi-asserted-by":"crossref","first-page":"S672","DOI":"10.1245\/s10434-014-3787-2","article-title":"Silencing of UCHL1 by CpG Promoter Hyper-Methylation is Associated With Metastatic Gastroenteropancreatic Well-Differentiated Neuroendocrine (Carcinoid) Tumors","volume":"21","author":"Kleiman","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib132","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/modpathol.2009.161","article-title":"MicroRNA Expression in Ileal Carcinoid Tumors: Down-regulation of MicroRNA-133a with Tumor Progression","volume":"23","author":"Ruebel","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib133","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/ERC-16-0044","article-title":"MicroRNAs associated with small bowel neuroendocrine tumours and their metastases","volume":"23","author":"Miller","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib134","doi-asserted-by":"crossref","first-page":"RP101153","DOI":"10.7554\/eLife.101153","article-title":"Subtypes and proliferation patterns of small intestine neuroendocrine tumors revealed by single-cell RNA sequencing","volume":"13","author":"Somech","year":"2026","journal-title":"eLife"},{"key":"10.1016\/j.beem.2026.102156_bib135","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/modpathol.2016.48","article-title":"Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets","volume":"29","author":"Andersson","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib136","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/PO.21.00047","article-title":"Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs","volume":"5","author":"Perez","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib137","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.gastro.2015.04.008","article-title":"A Hereditary Form of Small Intestinal Carcinoid Associated with a Germline Mutation in Inositol Polyphosphate Multikinase","volume":"149","author":"Sei","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2026.102156_bib138","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/ERC-17-0196","article-title":"A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors","volume":"24","author":"Dumanski","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib139","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/hmg\/ddab206","article-title":"WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas","volume":"30","author":"Aavikko","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2026.102156_bib140","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.annonc.2024.05.232","article-title":"224P Genomic patterns and clinical implications in gastroenteropancreatic neuroendocrine neoplasms","volume":"35","author":"Moffat","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib141","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.humpath.2019.02.007","article-title":"Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets","volume":"87","author":"Park","year":"2019","journal-title":"Human Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib142","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12022-014-9315-x","article-title":"Neuroendocrine pathology of the stomach: the Parma contribution","volume":"25","author":"Bordi","year":"2014","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib143","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4251\/wjgo.v15.i8.1497","article-title":"Gastric neuroendocrine tumors in a BRCA2 germline mutation carrier: A case report","volume":"15","author":"Zhang","year":"2023","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib144","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.3390\/cells10123500","article-title":"Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive Acid-Base Imbalance in Gastric Neuroendocrine Tumors and Uncover a Novel Mechanism for a Co-Occurring Polyautoimmune Scenario","volume":"10","author":"Calvete","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.beem.2026.102156_bib145","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1093\/hmg\/ddv054","article-title":"Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour","volume":"24","author":"Calvete","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2026.102156_bib146","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s10120-017-0723-8","article-title":"A cumulative effect involving malfunction of the PTH1R and ATP4A genes explains a familial gastric neuroendocrine tumor with hypothyroidism and arthritis","volume":"20","author":"Calvete","year":"2017","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib147","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2021-000765","article-title":"Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours","volume":"8","author":"Rico","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.beem.2026.102156_bib148","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/s41379-018-0082-y","article-title":"Whole exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1","volume":"31","author":"No\u00eb","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib149","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/gut.2006.108910","article-title":"Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions","volume":"56","author":"Anlauf","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.beem.2026.102156_bib150","doi-asserted-by":"crossref","first-page":"16207","DOI":"10.1002\/cam4.6281","article-title":"Molecular typing and mutational characterization of rectal neuroendocrine neoplasms","volume":"12","author":"Duan","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.beem.2026.102156_bib151","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41419-024-07232-1","article-title":"Whole-exome sequencing reveals novel genomic signatures and potential therapeutic targets during the progression of rectal neuroendocrine neoplasm","volume":"15","author":"Xu","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.beem.2026.102156_bib152","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1213931","article-title":"Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases","volume":"5","author":"Ko\u015falo\u011flu","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.beem.2026.102156_bib153","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.humpath.2018.03.026","article-title":"Genomic profile of appendiceal goblet cell carcinoid is distinct compared to appendiceal neuroendocrine tumor and conventional adenocarcinoma","volume":"77","author":"Wen","year":"2018","journal-title":"Human Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib154","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/ERC-22-0015","article-title":"Exploratory Genomic Analysis of High Grade Neuroendocrine Neoplasms Across Diverse Primary Sites","volume":"29","author":"Sun","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib155","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/his.15002","article-title":"Clinicopathological and genetic characteristics of gastric neuroendocrine tumour (NET) G3 and comparisons with neuroendocrine carcinoma and NET G2","volume":"83","author":"Chen","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.beem.2026.102156_bib156","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41416-024-02705-8","article-title":"Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasms","volume":"131","author":"Angerilli","year":"2024","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib157","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/cac2.12372","article-title":"Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract","volume":"42","author":"Wu","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.beem.2026.102156_bib158","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1002\/cam4.5633","article-title":"Genetic alterations of GI-NECs involving three main signaling pathways","volume":"12","author":"Dai","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.beem.2026.102156_bib159","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/path.6291","article-title":"PCDHGC3 hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas","volume":"263","author":"Cubiella","year":"2024","journal-title":"J Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12876-019-0942-z","article-title":"Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma","volume":"19","author":"Quaas","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.beem.2026.102156_bib161","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13257","article-title":"Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis","volume":"35","author":"Xing","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.beem.2026.102156_bib162","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ccell.2023.06.001","article-title":"An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets","volume":"41","author":"Griger","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2026.102156_bib163","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jso.24834","article-title":"Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma","volume":"117","author":"Idrees","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib164","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ijc.31828","article-title":"BRAFV600E mutation: A promising target in colorectal neuroendocrine carcinoma","volume":"144","author":"Dizdar","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215799","article-title":"Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma","volume":"543","author":"Shimizu","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.beem.2026.102156_bib166","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1002\/ijc.70367","article-title":"Molecular\u2013clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomas","volume":"158","author":"Morken","year":"2026","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218285","article-title":"Recent advances in the management of pancreatic neuroendocrine tumors: From diagnosis, treatment to biology","volume":"641","author":"Dai","year":"2026","journal-title":"Cancer Lett"},{"key":"10.1016\/j.beem.2026.102156_bib168","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.70302","article-title":"Endoscopic Ultrasound for the Management of Pancreatic Neuroendocrine Tumors: Diagnosis, Treatment, and Future Perspectives","author":"Bruni","year":"2026","journal-title":"J Gastro Hepatol"},{"key":"10.1016\/j.beem.2026.102156_bib169","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ueg2.12710","article-title":"Pancreatic Neuroendocrine Neoplasms: Classification and Novel Role of Endoscopic Ultrasound in Diagnosis and Treatment Personalization","volume":"13","author":"Tacelli","year":"2025","journal-title":"UEG J"},{"key":"10.1016\/j.beem.2026.102156_bib170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semcancer.2025.03.005","article-title":"Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis","volume":"112","author":"Tacelli","year":"2025","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.beem.2026.102156_bib171","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1016\/j.ijsu.2015.12.052","article-title":"Pancreatic neuroendocrine tumors: Nosography, management and treatment","volume":"28","author":"Orditura","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.beem.2026.102156_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103648","article-title":"Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification","volume":"172","author":"Ishida","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.beem.2026.102156_bib173","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.beem.2026.102156_bib174","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12022-025-09889-6","article-title":"Molecular Subtypes of Pancreatic Neuroendocrine Tumors Mutated in MEN1\/DAXX\/ATRX Explain Biological Variability","volume":"36","author":"Avanthay","year":"2025","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib175","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ccell.2025.03.016","article-title":"Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups","volume":"43","author":"Ji","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2026.102156_bib176","article-title":"Molecular taxonomy of pancreatic neuroendocrine tumors reveals BEND2-fusions-driven transcriptional plasticity and therapeutic vulnerabilities","volume":"7","author":"Lu","year":"2026","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.beem.2026.102156_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100863","article-title":"Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis","volume":"38","author":"Wood-Trageser","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib178","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX \/ ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.beem.2026.102156_bib179","doi-asserted-by":"crossref","first-page":"8510","DOI":"10.1038\/s41598-024-58874-2","article-title":"Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice","volume":"14","author":"Fuentes","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2026.102156_bib180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41698-025-01210-2","article-title":"CDKN2A homozygous deletions and TSC2 somatic mutations in metastatic pancreatic neuroendocrine tumors","volume":"10","author":"Jesus","year":"2025","journal-title":"Npj Precis Onc"},{"key":"10.1016\/j.beem.2026.102156_bib181","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11864-023-01085-0","article-title":"Management of Functional Pancreatic Neuroendocrine Neoplasms","volume":"24","author":"Magi","year":"2023","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib182","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2026.102156_bib183","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13318","article-title":"European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes","volume":"35","author":"Hofland","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.beem.2026.102156_bib184","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13343","article-title":"European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours","volume":"35","author":"Kos-Kud\u0142a","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.beem.2026.102156_bib185","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/ncomms3810","article-title":"Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1","volume":"4","author":"Cao","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102156_bib186","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/gutjnl-2018-317233","article-title":"Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system","volume":"69","author":"Hong","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.beem.2026.102156_bib187","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1158\/2159-8290.CD-15-0068","article-title":"A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics","volume":"5","author":"Sadanandam","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beem.2026.102156_bib188","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.trsl.2022.07.005","article-title":"Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors","volume":"251","author":"Pedraza-Arevalo","year":"2023","journal-title":"Transl Res"},{"key":"10.1016\/j.beem.2026.102156_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102090","article-title":"Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response","volume":"35","author":"Alors-P\u00e9rez","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.beem.2026.102156_bib190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12022-026-09923-1","article-title":"An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular Subgroups","volume":"37","author":"Bl\u00e1zquez-Encinas","year":"2026","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib191","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/cncr.28721","article-title":"Gastroenteropancreatic high-grade neuroendocrine carcinoma","volume":"120","author":"Sorbye","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib192","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3348\/kjr.2018.0040","article-title":"What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms","volume":"20","author":"Choe","year":"2019","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.beem.2026.102156_bib193","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/bjc.2016.229","article-title":"Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study","volume":"115","author":"Vijayvergia","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib194","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib195","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1158\/1078-0432.CCR-16-3135","article-title":"Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study","volume":"23","author":"Hijioka","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2026.102156_bib196","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12022-016-9432-9","article-title":"Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms","volume":"27","author":"La Rosa","year":"2016","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib197","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2017.04.002","article-title":"Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review","volume":"56","author":"Girardi","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.beem.2026.102156_bib198","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11864-022-00968-y","article-title":"An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN)","volume":"23","author":"Jacob","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib199","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/ejcts\/ezw107","article-title":"Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest Group","volume":"50","author":"Filosso","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.beem.2026.102156_bib200","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/SLA.0b013e3181dd4ec4","article-title":"Thymic Neuroendocrine Tumors: A SEER Database Analysis of 160 Patients","volume":"251","author":"Gaur","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2026.102156_bib201","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jtcvs.2014.08.061","article-title":"Outcome of primary neuroendocrine tumors of the thymus: A joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases","volume":"149","author":"Filosso","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.beem.2026.102156_bib202","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","article-title":"The 2015 WHO Classification of Tumors of the Thymus: Continuity and Changes","volume":"10","author":"Marx","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib203","doi-asserted-by":"crossref","first-page":"S1448","DOI":"10.21037\/jtd.2017.02.02","article-title":"Neuroendocrine tumors of the thymus and mediastinum","volume":"9","author":"Bohnenberger","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.beem.2026.102156_bib204","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/gcc.22183","article-title":"Tumor genetics and survival of thymic neuroendocrine neoplasms: A multi-institutional clinicopathologic study","volume":"53","author":"Str\u00f6bel","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib205","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jtho.2019.04.015","article-title":"Molecular Classification of Neuroendocrine Tumors of the Thymus","volume":"14","author":"Dinter","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.beem.2026.102156_bib206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00428-017-2130-2","article-title":"Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed \u00df-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift","volume":"471","author":"Fabbri","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.beem.2026.102156_bib207","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00000658-199807000-00015","article-title":"Thymic carcinoids in multiple endocrine neoplasia type 1","volume":"228","author":"Teh","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2026.102156_bib208","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol & Metab"},{"key":"10.1016\/j.beem.2026.102156_bib209","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/jc.2002-021314","article-title":"Prospective Study of Thymic Carcinoids in Patients with Multiple Endocrine Neoplasia Type 1","volume":"88","author":"Gibril","year":"2003","journal-title":"J Clin Endocrinol & Metab"},{"key":"10.1016\/j.beem.2026.102156_bib210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2004.10.027","article-title":"Chromosomal imbalances in sporadic neuroendocrine tumours of the thymus","volume":"223","author":"Rieker","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.beem.2026.102156_bib211","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/modpathol.3800246","article-title":"Comparative genomic hybridization analysis of thymic neuroendocrine tumors","volume":"18","author":"Pan","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beem.2026.102156_bib212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/EJE-16-0546","article-title":"Whole exome sequencing of thymic neuroendocrine tumor with ectopic ACTH syndrome","volume":"176","author":"Li","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102156_bib213","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cllc.2020.11.010","article-title":"Mutation profile of thymic carcinoma and thymic neuroendocrine tumor by targeted next-generation sequencing","volume":"22","author":"Sakane","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.beem.2026.102156_bib214","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1097\/CM9.0000000000002852","article-title":"Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways","volume":"136","author":"Wang","year":"2023","journal-title":"Chin Med J (Engl)"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:17:42Z","timestamp":1788812262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X26000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":214,"alternative-id":["S1521690X26000783"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102156","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HeteroGeNETics: Neuroendocrine tumor genetics reflect their heterogeneous complex diversity","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102156"}}